Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.
Yanai H, Adachi H, Hakoshima M, Katsuyama H.
Int J Mol Sci. 2021 Aug 26;22(17):9221. doi: 10.3390/ijms22179221.
PMID:34502127
Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials.
Xu C, Smith ER, Tiong MK, Ruderman I, Toussaint ND.
J Am Soc Nephrol. 2022 May;33(5):1011-1032. doi: 10.1681/ASN.2021101327. Epub 2022 Mar 1.
PMID:35232774
Intestinal ischemia.
Debus ES, Müller-Hülsbeck S, Kölbel T, Larena-Avellaneda A.
Int J Colorectal Dis. 2011 Sep;26(9):1087-97. doi: 10.1007/s00384-011-1196-6. Epub 2011 May 4.
PMID:21541663
SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease.
Dong QQ, Tu YC, Gao P, Liao QQ, Zhou P, Zhang H, Shu HP, Sun LL, Feng L, Yao LJ.
Theranostics. 2024 Jan 1;14(2):861-878. doi: 10.7150/thno.87317. eCollection 2024.
PMID:38169564
Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease.
Felsenfeld AJ, Levine BS, Rodriguez M.
Semin Dial. 2015 Nov-Dec;28(6):564-77. doi: 10.1111/sdi.12411. Epub 2015 Aug 25.